Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer

NCT00044993 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: Ad5CMV-p53 gene
DRUG: docetaxel
DRUG: doxorubicin hydrochloride
PROCEDURE: conventional surgery
PROCEDURE: neoadjuvant therapy

Sponsor

Introgen Therapeutics